BioWorld Today

BioWorld Today: "In a merger valued at $670 million, Seattle-based biotech Ikaria Inc. is joining forces with Clinton, N.J.-based INO Therapeutics Inc., the specialty pharmaceutical division of The Linde Group. The new company, Ikaria Holdings, will focus on gas-based critical care therapeutics."